Phase 3 VALOR Lyme Disease Trial: Valneva and Pfizer Announce Primary Vaccination Series CompletionGlobeNewsWire • 07/17/24
European Commission didn't provide enough information about COVID-19 vaccine deals, EU court saysMarket Watch • 07/17/24
Forget Medical Properties Trust: This High-Yielding Dividend Stock Is a Much Better BuyThe Motley Fool • 07/16/24
With Oral Anti-Obesity Candidate Development, Pfizer Seeks Relevant And Competitive Presence - Goldman SachsBenzinga • 07/12/24
Pfizer says it has identified and selected a preferred formulation for its one-a-day obesity pillMarket Watch • 07/11/24